slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 89,371-89,400
Pages 3,685
Rows per page 30
Component
89,371-89,400 of 110,539
23
Maersk | Results Presentation Deck | 40 slidesMaersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
29
Maersk | Results Presentation Deck | 40 slidesMaersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
40
Standard corporate colophon page listing board members, committees, auditors, and production credits.Maersk | Results Presentation Deck | 40 slides · Maersk
Shareholder letter Investor relations Beat · Visualization1 hit
32
Maersk | Results Presentation Deck | 42 slidesMaersk | Results Presentation Deck | 42 slides · Maersk
Conference presentation Investor relations 1 hit
04
The slide outlines clinical trial progress (THIO-101, 102, 103), regulatory designations, and intellectual property status.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
10
The slide illustrates the biological interaction between THIO (telomere targeting) and CPIs (checkpoint inhibitors) to induce tumor cell death.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide outlines a clinical trial process flow from initial NSCLC 2L+ patient entry through randomization to expansion.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Why Now1 hit
13
The slide uses a bulleted list to present clinical trial safety findings.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
15
The slide highlights exceptional progression-free survival in a high-need patient population.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
18
The chart shows tumor volume over time, highlighting the superior performance of the THIO + Atezo combination compared to monotherapies and control.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
19
The table compares clinical trial metrics for THIO-101 targets versus existing chemotherapy SoC.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
22
The slide uses two line charts to demonstrate tumor volume reduction and the effect of rechallenge.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
23
The table compares clinical endpoints (Toxicity, ORR, PFS, OS) for the current standard of care (LONSURF) against the trial's goals.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
26
Shows two distinct experiments: initial tumor growth inhibition and subsequent rechallenge immunity.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
06
The chart compares quarterly container volumes between 2022 and 2023.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
07
The chart compares 2022 vs 2023 quarterly container volumes.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
08
The chart compares 2022 and 2023 quarterly container volumes.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
09
The chart shows a comparison of container volume by quarter for 2022 and 2023, with a specific callout for the 7.2% decline in Q2.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
10
The chart shows quarterly operating income for 2022 and 2023, with Q2 2023 highlighted as a range.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Satisfaction1 hit
08
The slide uses a grid-based layout to categorize client deals by service line, with a sidebar for industry recognition.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
Includes an IFR award badge in the top right corner.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
Includes an award badge from The Banker for 2020.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
Includes a 'Deals of the Year 2022' badge from The Banker.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Loop · Golden Circle1 hit
17
The expansion data covers the last twelve months (LTM) ending June 2023.Moelis & Company | Investor Presentation Deck | 24 slides · Moelis
Conference presentation Investor relations Loop · Golden Circle1 hit
06
Nano Dimension | Mergers and Acquisitions Presentation Deck | 36 slidesNano Dimension | Mergers and Acquisitions Presentation Deck | 36 slides · Nano Dimension
Activist deck Investment bank 1 hit
20
Uses a combination of stacked bar charts for revenue and side-by-side bar charts for net income to highlight the disparity in performance.Nano Dimension | Mergers and Acquisitions Presentation Deck | 36 slides · Nano Dimension
Activist deck Investment bank 1 hit
22
Uses a treemap-style visualization to represent market share distribution.Nano Dimension | Mergers and Acquisitions Presentation Deck | 36 slides · Nano Dimension
Activist deck Investment bank 1 hit
23
The chart contrasts Nano's lower acquisition multiples (0.8x-2.4x) against higher market comparables (3.2x-10.3x).Nano Dimension | Mergers and Acquisitions Presentation Deck | 36 slides · Nano Dimension
Activist deck Investment bank 1 hit
05
The slide includes a detailed table of assets, liabilities, and equity, alongside bulleted commentary on key drivers of change.New York Community Bancorp | Results Presentation Deck | 31 slides · New York Community Bancorp
Conference presentation Investor relations Beat · NeedLoop · Logic Chain1 hit
08
The chart illustrates the net change in deposits over the second quarter of 2023.New York Community Bancorp | Results Presentation Deck | 31 slides · New York Community Bancorp
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit